MLLCF Stock Analysis
ML
Uncovered
Molecular Partners AG is uncovered by Eyestock quantitative analysis.
Market cap $B
0.158
Dividend yield
—
Shares outstanding
36.057 B
Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The company is headquartered in Schlieren, Zuerich and currently employs 175 full-time employees. The company went IPO on 2014-10-22. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
View Section: Eyestock Rating